150 related articles for article (PubMed ID: 22982756)
1. Lamotrigine monotherapy does not provide protection against the loss of optic nerve axons in a rat model of ocular hypertension.
Marina N; Sajic M; Bull ND; Hyatt AJ; Berry D; Smith KJ; Martin KR
Exp Eye Res; 2012 Nov; 104():1-6. PubMed ID: 22982756
[TBL] [Abstract][Full Text] [Related]
2. Functional and structural evaluation of lamotrigine treatment in rat models of acute and chronic ocular hypertension.
Sandalon S; Könnecke B; Levkovitch-Verbin H; Simons M; Hein K; Sättler MB; Bähr M; Ofri R
Exp Eye Res; 2013 Oct; 115():47-56. PubMed ID: 23810807
[TBL] [Abstract][Full Text] [Related]
3. The dark phase intraocular pressure elevation and retinal ganglion cell degeneration in a rat model of experimental glaucoma.
Kwong JM; Vo N; Quan A; Nam M; Kyung H; Yu F; Piri N; Caprioli J
Exp Eye Res; 2013 Jul; 112():21-8. PubMed ID: 23603611
[TBL] [Abstract][Full Text] [Related]
4. A novel neuroprotectant against retinal ganglion cell damage in a glaucoma model and an optic nerve crush model in the rat.
Maeda K; Sawada A; Matsubara M; Nakai Y; Hara A; Yamamoto T
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):851-6. PubMed ID: 14985301
[TBL] [Abstract][Full Text] [Related]
5. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats.
Levkovitch-Verbin H; Quigley HA; Martin KR; Valenta D; Baumrind LA; Pease ME
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):402-10. PubMed ID: 11818384
[TBL] [Abstract][Full Text] [Related]
6. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma.
Ebneter A; Chidlow G; Wood JP; Casson RJ
Arch Ophthalmol; 2011 Oct; 129(10):1337-44. PubMed ID: 21987677
[TBL] [Abstract][Full Text] [Related]
7. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss.
Soto I; Pease ME; Son JL; Shi X; Quigley HA; Marsh-Armstrong N
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):434-41. PubMed ID: 20811062
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of R(-)-1-(benzo[b]thiophen-5-yl)-2- [2-(N,N-diethylamino)ethoxy]ethanol hydrochloride (T-588) against retinal ganglion cell death induced by elevated intraocular pressure in rat.
Karim MZ; Gu Z; Sawada A; Taniguchi T; Kawase K; Yamamoto T; Kitazawa Y
Jpn J Ophthalmol; 2002; 46(6):621-6. PubMed ID: 12543187
[TBL] [Abstract][Full Text] [Related]
10. Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury.
Johnson EC; Cepurna WO; Choi D; Choe TE; Morrison JC
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):412-9. PubMed ID: 25525172
[TBL] [Abstract][Full Text] [Related]
11. Morphometric changes in the rat optic nerve following short-term intermittent elevations in intraocular pressure.
Joos KM; Li C; Sappington RM
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6431-40. PubMed ID: 20688743
[TBL] [Abstract][Full Text] [Related]
12. The effects of age on mitochondria, axonal transport, and axonal degeneration after chronic IOP elevation using a murine ocular explant model.
Kimball EC; Jefferys JL; Pease ME; Oglesby EN; Nguyen C; Schaub J; Pitha I; Quigley HA
Exp Eye Res; 2018 Jul; 172():78-85. PubMed ID: 29625080
[TBL] [Abstract][Full Text] [Related]
13. A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria.
Kimball EC; Pease ME; Steinhart MR; Oglesby EN; Pitha I; Nguyen C; Quigley HA
Exp Eye Res; 2017 Jul; 160():106-115. PubMed ID: 28414059
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.
Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B
Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996
[TBL] [Abstract][Full Text] [Related]
15. Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.
Quigley HA; Cone FE; Gelman SE; Yang Z; Son JL; Oglesby EN; Pease ME; Zack DJ
Exp Eye Res; 2011 Apr; 92(4):299-305. PubMed ID: 21272576
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of a dual ET
Kodati B; McGrady NR; Jefferies HB; Stankowska DL; Krishnamoorthy RR
Mol Vis; 2022; 28():165-177. PubMed ID: 36274816
[TBL] [Abstract][Full Text] [Related]
17. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure.
Shareef S; Sawada A; Neufeld AH
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2884-91. PubMed ID: 10549648
[TBL] [Abstract][Full Text] [Related]
18. Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model.
Steinhart MR; Cone FE; Nguyen C; Nguyen TD; Pease ME; Puk O; Graw J; Oglesby EN; Quigley HA
Mol Vis; 2012; 18():1093-106. PubMed ID: 22701298
[TBL] [Abstract][Full Text] [Related]
19. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice.
Sappington RM; Carlson BJ; Crish SD; Calkins DJ
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):207-16. PubMed ID: 19850836
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of retinal nerve fiber layer thickness and axonal transport 1 and 2 weeks after 8 hours of acute intraocular pressure elevation in rats.
Abbott CJ; Choe TE; Lusardi TA; Burgoyne CF; Wang L; Fortune B
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):674-87. PubMed ID: 24398096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
